The Amiodarone--Class I Agent Combination Increases Refractoriness, Conduction, and the Number of Electrophysiologic Studies. But Does It Increase Survival Rate?
Circulation - United States
doi 10.1161/01.cir.84.1.429
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 1991
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)